# A Study of Cephalexin Liquid in Healthy Participants

> **NCT02490670** · PHASE1 · COMPLETED · sponsor: **Eli Lilly and Company** · enrollment: 28 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Cephalexin

## Key facts

- **NCT ID:** NCT02490670
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-07
- **Primary completion:** 2015-07
- **Final completion:** 2015-07
- **Target enrollment:** 28 (ACTUAL)
- **Last updated:** 2016-10-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02490670

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02490670, "A Study of Cephalexin Liquid in Healthy Participants". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02490670. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*